Bioethics Statistics

Total Valuation

Bioethics has a market cap or net worth of 18,361. The enterprise value is 589,390.

Market Cap	18,361
Enterprise Value	589,390

Important Dates

The next estimated earnings date is Tuesday, April 14, 2026.

Earnings Date	Apr 14, 2026
Ex-Dividend Date	n/a

Share Statistics

Bioethics has 3.60 million shares outstanding.

Current Share Class	3.60M
Shares Outstanding	3.60M
Shares Change (YoY)	n/a
Shares Change (QoQ)	+126.12%
Owned by Insiders (%)	75.14%
Owned by Institutions (%)	n/a
Float	395,184

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	-0.02
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-3.33
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.02

Current Ratio	0.02
Quick Ratio	0.02
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-2.27

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-1,037.17%
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	13.19%
Weighted Average Cost of Capital (WACC)	6.13%
Revenue Per Employee	n/a
Profits Per Employee	-176,955
Employee Count	1
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -99.54% in the last 52 weeks. The beta is -6.47, so Bioethics's price volatility has been lower than the market average.

Beta (5Y)	-6.47
52-Week Price Change	-99.54%
50-Day Moving Average	1.91
200-Day Moving Average	4.65
Relative Strength Index (RSI)	42.87
Average Volume (20 Days)	724

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-122,817
Pretax Income	-176,955
Net Income	-176,955
EBITDA	n/a
EBIT	-122,817
Earnings Per Share (EPS)	-0.12

Balance Sheet

The company has 14,664 in cash and 585,689 in debt, with a net cash position of -571,025 or -0.16 per share.

Cash & Cash Equivalents	14,664
Total Debt	585,689
Net Cash	-571,025
Net Cash Per Share	-0.16
Equity (Book Value)	-931,220
Book Value Per Share	-0.28
Working Capital	-931,220

Cash Flow

Operating Cash Flow	-150,429
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Bioethics does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-31.53%
Shareholder Yield	-31.53%
Earnings Yield	-963.75%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on November 2, 2020. It was a reverse split with a ratio of 0.1.

Last Split Date	Nov 2, 2020
Split Type	Reverse
Split Ratio	0.1

Scores

Altman Z-Score	n/a
Piotroski F-Score	1